NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
(Total Views: 270)
Posted On: 11/10/2021 4:20:26 PM
NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Eyeing Opportunities in the US, UK and EU, Generating Interest Among Latin American and Caribbean Countries
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the initial rollout by partnering with the Shoppers Drug Mart pharmacy network in Ontario, Canada. The company anticipates continuing to expand through Shoppers Drug Mart’s almost 1,800 pharmacies across Canada, adding other pharmacies, and then entering the United States and the United Kingdom. Avricore is excited about opportunities in the United Kingdom and EU, a market bigger than China. “Bremner said Avricore Health is also generating interest among Latin American and Caribbean countries for applications of its network in travel-related infectious disease diagnostics.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the initial rollout by partnering with the Shoppers Drug Mart pharmacy network in Ontario, Canada. The company anticipates continuing to expand through Shoppers Drug Mart’s almost 1,800 pharmacies across Canada, adding other pharmacies, and then entering the United States and the United Kingdom. Avricore is excited about opportunities in the United Kingdom and EU, a market bigger than China. “Bremner said Avricore Health is also generating interest among Latin American and Caribbean countries for applications of its network in travel-related infectious disease diagnostics.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)